ABSTRACT. The aim of this study was to perform an association study between seven Fyn-binding protein gene (FYB)-tag single nucleotide polymorphisms (SNPs) and type I diabetes mellitus (T1DM), as well as with disease age of onset. We also assessed the role of FYB SNPs in the insurgence of autoimmune polyglandular syndrome type III (APSIII), characterized by the simultaneous presence of autoimmune thyroid disease and celiac disease, in patients with T1DM from a Northeastern Brazilian population. One hundred and seventy-seven patients with T1DM and 190 healthy individuals were genotyped for seven tag SNPs, covering most of the FYB locus, using real-time polymerase chain reaction amplification. There was no significant difference in the distribution of allele and genotype frequencies among patients and healthy individuals. Moreover, none of the tag SNPs were associated either to T1DM age of onset or to the insurgence of APSIII. However, since the FYB protein is a key component in T cell response, its gene variants might play a role in protein function, which might be testable in a population with different genetic backgrounds or by using functional assays.
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INTRODUCTION
Type I diabetes mellitus (T1DM) is an organ-specific autoimmune disease characterized by the destruction of pancreatic β islet cells leading to the impaired production of insulin. The imbalance of the immune system in T1DM patients might lead to autoimmune polyglandular syndrome type III (APSIII), characterized by the simultaneous presence of autoimmune thyroid disease (AITD) and/or celiac disease (CD). The attack by auto-reactive T cells on the pancreas is the main immunological feature in T1DM. Deregulation of T cell homeostasis is a key event in the maintenance of self-tolerance breakdown in T1DM pathogenesis (Dittmar and Kahaly, 2010) . The activation of the T cell surface receptor (TCR) triggers intracellular signaling cascades, which result in T cell activation, differentiation, and acquisition of effector function or apoptosis. Adaptor proteins play a critical role in connecting TCR signals from the cell surface to distal signaling pathways. Alterations in the concentration and function of the adaptor proteins may impair the activation and function of T lymphocytes (Griffiths et al., 2001; Wang and Rudd, 2008) .
The Fyn-binding protein (FYB) is an adaptor protein, also known as adhesion and degranulation promoting adapter protein (ADAP). This protein is involved in T cell signaling activation, and participates in integrin-mediated adhesion, cytoskeletal actin reorganization, and in the stability and duration of cell-cell contact (Griffiths et al., 2001; Wang and Rudd, 2008; Pauker et al., 2011) . Since Zou et al. (2008) observed that the loss of FYB leads to defective thymocyte selection and a striking enhancement of T1DM incidence in FYB knockout mice, it could be speculated that this protein might participate in disease establishment. Single nucleotide polymorphisms (SNPs) within the FYB gene (5p13.1) might alter the concentration or function of the protein and, as consequence, contribute to T1DM development. Therefore, in this study we assessed the possible association between seven FYB-tag SNPs (representative SNPs of a group of polymorphisms with high linkage disequilibrium) and the development of T1DM as well as with disease age of onset. In addition, we also assessed the role of FYB polymorphisms in the development of AITD and CD in patients with T1DM from a Northeastern Brazilian population.
MATERIAL AND METHODS

Subjects
This study included 177 patients (mean age 13.57 ± 5 years; 52% women and 48% men; mean age at disease onset 7.57 ± 4.18 years) from the three major pediatric endocrinol- . For 3 patients in the T1DM group the information about other autoimmune diseases was missing. The diagnosis for AITD and CD was made as described by Araujo et al. (2009) .
The control group comprised 190 healthy individuals (mean age 37.76 ± 15.08 years; 85% women and 15% men) without family history of autoimmune disorders and recruited from the same geographic area as the patient group. This study was carried out with advanced approval from the Local Ethics Committee (IMIP Numbers: 762/2006 and 1717/2010) and written informed consent was obtained from all participants.
FYB genotyping
Genomic DNA was isolated from peripheral blood samples using the DNA Wizard Genomic DNA Purification Kit (Promega Madison, WI, USA) following the manufacturer protocol. SNP genotyping was performed with fluorogenic allele-specific probes (Applied Biosystems, Foster City, CA, USA), using an ABI7500 sequence detection system (Ap- 
Statistical analysis
Genotype frequencies and Hardy-Weinberg Equilibrium (HWE) were evaluated by the Genotype Transposer software (Cox and Canzian, 2001 ). The statistical significance of differences in allele and genotype frequencies between patients and controls were calculated by Fisher's exact test. The SNPassoc package in the R 3.0.0 software platform (www.r-project. org/) was used to calculate the odds ratios (ORs) and 95% confidence intervals (95%CIs). P values < 0.05 were considered to be statistically significant. The Haploview software (www. broad.mit.edu/mpg/haploview) was used for linkage disequilibrium (LD) analysis in the association of FYB polymorphisms and T1DM.
RESULTS
The distribution of allele and genotype frequencies of the seven FYB SNPs studied in patients with T1DM and healthy individuals is depicted in Table 1 . No significant differences were observed when comparing the allele and genotype frequencies between patients and controls. When analyzing the frequencies of the tested tag SNPs in APSIII and age at onset, no statistically significant results were found. In addition, no significant association was found between the haplotypes for the seven SNPs and T1DM susceptibility (data not shown). (65) 12 (60) 153 (62) 224 (63) 239 ( (97) 18 (90) 235 (96) 339 (96) 368 (97) A 0 (0) P = 0.60 2 (3) P = 0.87 2 (10) P = 0.32 11 (4) P = 0.52 15 (4) P = 0.43 12 (3) G/G 4 (100) 35 (95) 8 (80) 112 (91) 162 (92) 178 ( (65) 115 (65) 128 (67) T/C 2 (50) P = 0.72 12 (32) P = 0.74 3 (30) P = 0.78 42 (34) P = 0.37 60 (34) P = 0.11 52 (27) C/C 0 (0) P = 0.32 1 (3) P = 0.87 0 (0) P = 0.98 1 (1) P = 0.09 2 (1) P = 0.07 10 (6)
